GB Patent

GB0325605D0 — Combination of organic compounds

Assigned to Novartis AG · Expires 2003-12-10 · 22y expired

What this patent protects

The invention relates to a combination, such as a combined preparation or pharmaceutical composition, respectively, comprising (i) an AT1-receptor antagonist or a pharmaceutically acceptable salt thereof, and (ii) the diuretic amiloride or triameterine or a pharmaceutically accep…

USPTO Abstract

The invention relates to a combination, such as a combined preparation or pharmaceutical composition, respectively, comprising (i) an AT1-receptor antagonist or a pharmaceutically acceptable salt thereof, and (ii) the diuretic amiloride or triameterine or a pharmaceutically acceptable salt thereof, and (iii) a further diuretic or a pharmaceutically acceptable salt thereof.

Drugs covered by this patent

Patent Metadata

Patent number: GB0325605D0
Jurisdiction: GB
Classification: —
Expires: 2003-12-10
Drug substance claim: No
Drug product claim: No
Assignee: Novartis AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.